LEMAITRE VASCULAR INC - Common Stock (LMAT)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
18,810,702
Total 13F shares
18,775,944
Share change
+453,101
Total reported value
$872,420,057
Put/Call ratio
0%
Price per share
$46.47
Number of holders
175
Value change
+$20,477,763
Number of buys
88
Number of sells
82

Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2022

As of 31 Mar 2022, LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,775,944 shares. The largest 10 holders included BlackRock Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Ranger Investment Management, L.P., KENNEDY CAPITAL MANAGEMENT, INC., and Summit Creek Advisors LLC. This page lists 175 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.